Like many other companies and institutions around the world, we are experiencing interference with some of our systems within the TNT network.
We are implementing remediation steps as quickly as possible. We have implemented operational contingencies to continue to complete collections from customers with scheduled stops. For customers who do not have a regular stop, collection should be arranged via our customer service centers.
Customers may experience delays in the transit of shipments, particularly inter-continental or non-EU European delivery, as we work to remediate our systems. Additionally, if customers do not have the facility for self-labeling, they may also experience delays.
We are not able to collect shipments of dangerous goods at this time.
We regret any inconvenience to our customers.
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over almost 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
Through our continual investment in the development of our state of the art services; from cutting edge biomarker and companion diagnostics through to step changes in the management of the clinical trial data and the clinical supply chain to biocatalytic manufacture of API, Almac ensures we are always there to support you across the product development lifecycle.
Almac Awards ArchiveLearn more
Almac History, Culture and Values
Watch our History, Culture and Values Video to learn more about our background and vision for a successful future.Learn more
Company Overview Video
Learn more about our extensive pharmaceutical development and manufacturing services and global capabilities.Learn more
Almac is a global provider of pharmaceutical support services with thousands of employees situated throughout its global facilities. It is Almac’s policy to conduct all business in an honest and ethical manner.Learn more
Core Values & Vision
Our ultimate goal is to help advance human health globally. We are at the forefront of improving efficiency in the development of new medicines.Learn more
For more than 40 years, Almac has supported the global Biopharmaceutical industry with their drug development activities and bringing new drugs to market to advance human health.Learn more
As testament to our expertise and strong global performance, Almac is proud to have been recognised by various bodies and received an array of awards.Learn more
Sir Allen McClay
Northern Ireland lost its most passionate, visionary and generous man. Sir Allen McClay (Allen, as he preferred to be called) passed away on Tuesday 12th January, 2010.Learn more
Tax Strategy: Almac Approach
The Almac Group is a group of companies operating in the highly regulated and risk-averse pharmaceutical and biotech sectors. We adopt this same low risk strategy in our approach to our tax affairs and tax strategy.Learn more